Inventiva
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Inventiva and buy or sell other stocks, ETFs, and their options commission-free!About IVA
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors.
CEOAndrew Obenshain
CEOAndrew Obenshain
Employees119
Employees119
HeadquartersDaix, Bourgogne-Franche-Comte
HeadquartersDaix, Bourgogne-Franche-Comte
Founded2011
Founded2011
Employees119
Employees119
IVA Key Statistics
Market cap1.25B
Market cap1.25B
Price-Earnings ratio-1.54
Price-Earnings ratio-1.54
Dividend yield—
Dividend yield—
Average volume336.28K
Average volume336.28K
High today$6.10
High today$6.10
Low today$5.86
Low today$5.86
Open price$5.94
Open price$5.94
Volume435.99K
Volume435.99K
52 Week high$7.98
52 Week high$7.98
52 Week low$2.67
52 Week low$2.67
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.